ICU Medical, Inc. (NASDAQ:ICUI) Short Interest Down 10.7% in November

ICU Medical, Inc. (NASDAQ:ICUI) was the recipient of a large drop in short interest in November. As of November 15th, there was short interest totalling 582,400 shares, a drop of 10.7% from the October 31st total of 652,500 shares. Approximately 2.6% of the shares of the stock are sold short. Based on an average daily volume of 257,300 shares, the days-to-cover ratio is presently 2.3 days.

Insider Buying and Selling at ICU Medical

In related news, COO Christian B. Voigtlander sold 1,962 shares of the firm’s stock in a transaction on Monday, November 25th. The stock was sold at an average price of $169.08, for a total transaction of $331,734.96. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Vivek Jain sold 12,000 shares of ICU Medical stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $163.46, for a total value of $1,961,520.00. Following the completion of the transaction, the chief executive officer now directly owns 104,593 shares of the company’s stock, valued at approximately $17,096,771.78. This trade represents a 10.29 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 52,364 shares of company stock valued at $8,831,398. 6.70% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On ICU Medical

Hedge funds and other institutional investors have recently bought and sold shares of the business. Russell Investments Group Ltd. grew its position in shares of ICU Medical by 46.4% during the 1st quarter. Russell Investments Group Ltd. now owns 546 shares of the medical instruments supplier’s stock valued at $59,000 after purchasing an additional 173 shares in the last quarter. Jane Street Group LLC grew its position in shares of ICU Medical by 79.7% during the 1st quarter. Jane Street Group LLC now owns 89,852 shares of the medical instruments supplier’s stock valued at $9,643,000 after purchasing an additional 39,839 shares in the last quarter. Virtu Financial LLC purchased a new position in shares of ICU Medical during the 1st quarter valued at $288,000. Boston Partners purchased a new position in shares of ICU Medical during the 1st quarter valued at $790,000. Finally, CWM LLC grew its position in shares of ICU Medical by 18.5% during the 2nd quarter. CWM LLC now owns 767 shares of the medical instruments supplier’s stock valued at $91,000 after purchasing an additional 120 shares in the last quarter. Institutional investors own 96.10% of the company’s stock.

ICU Medical Stock Performance

ICUI stock traded down $3.00 during midday trading on Monday, reaching $160.96. 233,974 shares of the company’s stock traded hands, compared to its average volume of 273,983. The company has a 50-day moving average price of $174.60 and a two-hundred day moving average price of $147.67. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.03 and a current ratio of 2.29. ICU Medical has a 52 week low of $83.26 and a 52 week high of $196.26. The firm has a market capitalization of $3.94 billion, a PE ratio of -36.42 and a beta of 0.66.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the company. KeyCorp lifted their price objective on ICU Medical from $198.00 to $209.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 13th. Needham & Company LLC reiterated a “hold” rating on shares of ICU Medical in a research note on Wednesday, November 13th. Raymond James boosted their target price on ICU Medical from $158.00 to $190.00 and gave the stock an “outperform” rating in a research note on Thursday, September 12th. StockNews.com upgraded ICU Medical from a “hold” rating to a “buy” rating in a research note on Wednesday, November 20th. Finally, Jefferies Financial Group started coverage on shares of ICU Medical in a report on Monday, October 14th. They issued a “hold” rating and a $183.00 price target on the stock. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat, ICU Medical presently has an average rating of “Moderate Buy” and an average price target of $173.00.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.